Gregory J. Dore – 6 October 2016

Sarwa Darwish Murad, Edith M. Koehler, Elisabeth P.C. Plompen, Harry L.A. Janssen – 6 October 2016

Cheng‐Maw Ho, Hui‐Ling Chen – 6 October 2016

Christophe Renou, Bruno Lesgourgues, Gilles Macaigne, Arnaud Pauwels, Yann Le Bricquir, Jean Henrion, Faiza Khemissa, Emma Clair, Thierry Paupard, Agnes Pelaquier, Hélène Agostini, Anne‐Marie Roque‐Afonso – 6 October 2016

Robert J. Fontana, Ronald E. Engle, Robert H. Purcell, William M. Lee, On behalf of the ALFSG – 6 October 2016

Dimitri Tchernitchko, Virginie Scotet, Thibaud Lefebvre, Carine L'Hostis, Isabelle Gourlaouen, Marie‐Christine Merour, Khadidja Rebah, Katell Peoc'h, Suzanne Assari, Claude Ferec, Hervé Puy, Gérald Le Gac – 6 October 2016

Antonio Solinas, Diego F. Calvisi – 6 October 2016

Andrea Lauterio, Stefano Di Sandro, Salvatore Gruttadauria, Marco Spada, Fabrizio Di Benedetto, Umberto Baccarani, Enrico Regalia, Ernesto Melada, Alessandro Giacomoni, Matteo Cescon, Davide Cintorino, Giorgio Ercolani, Matteo Rota, Giorgio Rossi, Vincenzo Mazzaferro, Andrea Risaliti, Antonio Daniele Pinna, Bruno Gridelli, Luciano De Carlis – 6 October 2016 – Major concerns about donor morbidity and mortality still limit the use of living donor liver transplantation (LDLT) to overcome the organ shortage.

Luis Ibáñez‐Samaniego, Magdalena Salcedo, Javier Vaquero, Rafael Bañares – 6 October 2016 – De novo autoimmune hepatitis (DAIH) is a rare clinical condition with features that resemble those of autoimmune hepatitis (AIH) in patients undergoing liver transplantation (LT) for nonautoimmune liver disease. The diagnosis of this entity has been based on the presence of biochemical and histological patterns similar to those observed in the primary AIH, although several considerations must be taken into account.

Maja Thiele, Bjørn Stæhr Madsen, Aleksander Krag – 6 October 2016